Enzo Biochem Price to Free Cash Flow Ratio 2006-2021 | ENZ

Historical price to free cash flow ratio values for Enzo Biochem (ENZ) since 2006. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Enzo Biochem Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-01-21 3.17 0.00
2021-10-31 3.44 $-0.19 0.00
2021-07-31 3.26 $-0.08 0.00
2021-04-30 3.07 $-0.19 0.00
2021-01-31 2.82 $-0.29 0.00
2020-10-31 1.82 $-0.39 0.00
2020-07-31 2.38 $-0.41 0.00
2020-04-30 3.02 $-0.35 0.00
2020-01-31 2.51 $0.21 11.73
2019-10-31 3.16 $0.02 150.48
2019-07-31 3.91 $-0.07 0.00
2019-04-30 3.47 $-0.04 0.00
2019-01-31 3.76 $-0.55 0.00
2018-10-31 3.32 $-0.28 0.00
2018-07-31 4.42 $-0.10 0.00
2018-04-30 6.00 $-0.02 0.00
2018-01-31 7.36 $0.03 253.79
2017-10-31 9.85 $0.02 456.02
2017-07-31 10.85 $-0.04 0.00
2017-04-30 8.80 $0.70 12.61
2017-01-31 6.68 $0.62 10.77
2016-10-31 6.10 $0.82 7.48
2016-07-31 6.97 $1.11 6.30
2016-04-30 4.98 $0.42 11.83
2016-01-31 4.74 $0.45 10.57
2015-10-31 3.72 $0.22 16.86
2015-07-31 3.00 $-0.12 0.00
2015-04-30 2.80 $-0.19 0.00
2015-01-31 3.15 $-0.10 0.00
2014-10-31 5.22 $-0.04 0.00
2014-07-31 4.80 $-0.06 0.00
2014-04-30 4.20 $-0.12 0.00
2014-01-31 2.81 $-0.27 0.00
2013-10-31 2.49 $-0.32 0.00
2013-07-31 2.18 $-0.28 0.00
2013-04-30 2.24 $-0.23 0.00
2013-01-31 2.89 $-0.21 0.00
2012-10-31 2.00 $-0.17 0.00
2012-07-31 1.50 $-0.19 0.00
2012-04-30 2.74 $-0.28 0.00
2012-01-31 2.55 $-0.28 0.00
2011-10-31 2.86 $-0.26 0.00
2011-07-31 3.84 $-0.25 0.00
2011-04-30 3.99 $-0.19 0.00
2011-01-31 4.96 $-0.36 0.00
2010-10-31 4.31 $-0.39 0.00
2010-07-31 4.60 $-0.44 0.00
2010-04-30 5.97 $-0.50 0.00
2010-01-31 4.74 $-0.38 0.00
2009-10-31 5.51 $-0.42 0.00
2009-07-31 5.10 $-0.38 0.00
2009-04-30 4.10 $-0.38 0.00
2009-01-31 4.89 $-0.29 0.00
2008-10-31 5.77 $-0.34 0.00
2008-07-31 14.21 $-0.32 0.00
2008-04-30 8.18 $-0.19 0.00
2008-01-31 9.36 $-0.27 0.00
2007-10-31 12.11 $-0.26 0.00
2007-07-31 12.78 $-0.15 0.00
2007-04-30 16.81 $-0.39 0.00
2007-01-31 14.84 $-0.28 0.00
2006-10-31 14.30 $-0.38 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.155B $0.118B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.345B 9.06
Bio-Rad Laboratories (BIO.B) United States $18.101B 36.73
QIAGEN (QGEN) Netherlands $11.301B 19.14
Biohaven Pharmaceutical Holding (BHVN) United States $7.598B 0.00
Emergent Biosolutions (EBS) United States $2.503B 9.00
Arcus Biosciences (RCUS) United States $2.274B 0.00
Myovant Sciences (MYOV) United Kingdom $1.296B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.081B 0.00
Zymeworks (ZYME) Canada $0.538B 0.00
SQZ Biotechnologies (SQZ) United States $0.203B 0.00
Ambrx Biopharma (AMAM) United States $0.201B 0.00